April 24, 2020

Lysol Is Begging You Not to Listen to Donald Trump

“Under no circumstance should our disinfectant products be administered into the human body.”

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

It’s come to this: The maker of Lysol and Dettol has issued a statement emphatically pushing back against President Donald Trump’s stunning suggestion that injections of disinfectants could be used to treat patients infected with COVID-19.

“We must be clear that under no circumstance should our disinfectant products be administered into the human body (through injection, ingestion or any other route),” the company, Reckitt Benckiser, said on Friday. “As with all products, our disinfectant and hygiene products should only be used as intended and in line with usage guidelines.”

The statement comes hours after Trump openly mused about what he, wrongly, thought might be the potential benefits of disinfectant injections—as well as human exposure to ultraviolet light—in treating the coronavirus. “I see the disinfectant knocks it out in a minute,” Trump said at his daily coronavirus briefing on Thursday. “Is there a way we can do something like that, by injection inside or almost a cleaning? Because you see it gets in the lungs and it does a tremendous number on the lungs.”

In one camera angle, Dr. Deborah Birx, one of the top scientists on Trump’s coronavirus task force, is seen hanging her head as she takes in the president’s remarks. The apparent shock was echoed by public health experts and lawmakers who slammed Trump for, once again, spreading dangerous misinformation amid the pandemic. 

Trump has previously come under fire for his relentless promotion of the anti-malaria drug hydroxychloroquine to cure COVID-19, despite experts warning that the treatment had yet to be proven as an effective option. But in recent days, Trump has toned down that campaign, as some recent studies have suggested that hydroxychloroquine, which can have serious side effects, may not be helping patients. 

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate